• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

作者信息

Xu Gang, Zhou Xiao-Xiang, Xu Wei-Yu, Mao Yi-Lei

机构信息

Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan Road, Dong-Cheng District, Beijing, 100730, People's Republic of China.

Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-An Road, Xi-Cheng District, Beijing, 100050, People's Republic of China.

出版信息

World J Surg. 2020 Mar;44(3):1002-1003. doi: 10.1007/s00268-019-05318-y.

DOI:10.1007/s00268-019-05318-y
PMID:31822945
Abstract
摘要

相似文献

1
Letter to the Editor: Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.致编辑的信：肝切除治疗与代谢综合征相关的肝内胆管癌的短期和长期预后
World J Surg. 2020 Mar;44(3):1002-1003. doi: 10.1007/s00268-019-05318-y.
2
Reply to the Letter: "Laparoscopic Hepatectomy Has Superiority in R0 Resection over Open Hepatectomy for Intrahepatic Cholangiocarcinoma? The Evidence Is Unreliable".对信件《腹腔镜肝切除术在肝内胆管癌R0切除方面比开腹肝切除术更具优势？证据不可靠》的回复
J Gastrointest Surg. 2020 Feb;24(2):451-453. doi: 10.1007/s11605-019-04477-6. Epub 2019 Dec 10.
3
Letter to the Editor: Comment on "Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma".致编辑的信：对“小肝内胆管癌切除、消融和放疗后的生存情况比较”的评论
Ann Surg Oncol. 2023 Nov;30(12):7395-7396. doi: 10.1245/s10434-023-14212-w. Epub 2023 Aug 24.
4
Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video).左半肝切除术或左三叶切除术联合尾叶切除和肝外胆管切除治疗肝门部胆管癌（附视频）。
J Hepatobiliary Pancreat Sci. 2012 May;19(3):195-202. doi: 10.1007/s00534-011-0474-6.
5
Liver resection for recurrent hilar cholangiocarcinoma.复发性肝门部胆管癌的肝切除术
Br J Surg. 1993 Nov;80(11):1433. doi: 10.1002/bjs.1800801127.
6
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns.抗病毒治疗可提高接受肝切除的乙肝病毒感染合并肝内胆管癌患者的生存率：新的关注点。
J Hepatol. 2018 Jun;68(6):1315-1316. doi: 10.1016/j.jhep.2018.01.039. Epub 2018 Feb 20.
7
Surgical management of recurrent intrahepatic cholangiocellular carcinoma after liver resection.肝切除术后复发性肝内胆管细胞癌的外科治疗
Surgery. 2005 Jun;137(6):669-70. doi: 10.1016/j.surg.2005.03.007.
8
Reply to: "Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns".回复：“抗病毒治疗可提高接受肝切除的HBV感染合并肝内胆管癌患者的生存率：新的关注点”
J Hepatol. 2018 Jun;68(6):1316-1318. doi: 10.1016/j.jhep.2018.02.010. Epub 2018 Feb 17.
9
[Importance of repeated liver resection in recurrent intrahepatic cholangiocarcinoma].[重复肝切除术在复发性肝内胆管癌中的重要性]
Chirurg. 2017 Sep;88(9):804. doi: 10.1007/s00104-017-0484-2.
10
Clinicopathological Factors Associated With Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatectomy.肝切除术后肝内胆管癌患者预后相关的临床病理因素
JAMA Surg. 2018 Jan 1;153(1):91-92. doi: 10.1001/jamasurg.2017.3483.

本文引用的文献

1
Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.代谢综合征相关肝内胆管细胞癌行肝切除术的近期和远期疗效。
World J Surg. 2019 Aug;43(8):2048-2060. doi: 10.1007/s00268-019-04996-y.
2
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario.非酒精性脂肪性肝病、非酒精性脂肪性肝炎、代谢综合征与肝细胞癌——一种综合情况。
Hepatobiliary Surg Nutr. 2018 Apr;7(2):130-133. doi: 10.21037/hbsn.2018.01.01.
3
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
肝内胆管细胞癌患者的治疗与预后：系统评价和荟萃分析。
JAMA Surg. 2014 Jun;149(6):565-74. doi: 10.1001/jamasurg.2013.5137.
4
Physiological and biochemical basis of clinical liver function tests: a review.临床肝功能试验的生理和生化基础：综述。
Ann Surg. 2013 Jan;257(1):27-36. doi: 10.1097/SLA.0b013e31825d5d47.
5
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.倾向得分法在治疗组与非随机对照组比较中减少偏倚的应用
Stat Med. 1998 Oct 15;17(19):2265-81. doi: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b.